CIIHF(CIIHF)
CIIHF
No analyst ratings available
No analyst price targets available for CIIHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $86.92B | $94.50B | $102.83B |
| Low | $85.05B | $87.61B | $97.86B |
| High | $93.94B | $104.62B | $112.54B |
| EBITDA Avg | $30.63B | $33.31B | $36.24B |
| Low | $29.97B | $30.88B | $34.49B |
| High | $33.11B | $36.87B | $39.67B |
| EBIT Avg | $28.93B | $31.46B | $34.23B |
| Low | $28.31B | $29.16B | $32.58B |
| High | $31.27B | $34.83B | $37.46B |
| Net Income Avg | $4.61B | $5.04B | $5.57B |
| Low | $4.32B | $4.72B | $5.22B |
| High | $5.17B | $5.66B | $6.26B |
| EPS Avg | $2.42 | $2.65 | $2.93 |
| Low | $2.27 | $2.48 | $2.74 |
| High | $2.72 | $2.97 | $3.29 |
| Analysts (Rev / EPS) | 12 / 1 | 14 / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $20.19B | $21.00B | $22.42B | $23.35B | $23.35B | $24.29B |
| Low | $20.19B | $21.00B | $22.42B | $23.35B | $23.35B | $24.29B |
| High | $20.19B | $21.00B | $22.42B | $23.35B | $23.35B | $24.29B |
| EBITDA Avg | $7.12B | $7.40B | $7.90B | $8.23B | $8.23B | $8.56B |
| Low | $7.12B | $7.40B | $7.90B | $8.23B | $8.23B | $8.56B |
| High | $7.12B | $7.40B | $7.90B | $8.23B | $8.23B | $8.56B |
| EBIT Avg | $6.72B | $6.99B | $7.46B | $7.77B | $7.77B | $8.08B |
| Low | $6.72B | $6.99B | $7.46B | $7.77B | $7.77B | $8.08B |
| High | $6.72B | $6.99B | $7.46B | $7.77B | $7.77B | $8.08B |
| Net Income Avg | $8.03B | $8.45B | $9.00B | $9.49B | $9.49B | $9.99B |
| Low | $8.03B | $8.45B | $9.00B | $9.49B | $9.49B | $9.99B |
| High | $8.03B | $8.45B | $9.00B | $9.49B | $9.49B | $9.99B |
| EPS Avg | $0.53 | $0.55 | $0.59 | $0.62 | $0.62 | $0.66 |
| Low | $0.53 | $0.55 | $0.59 | $0.62 | $0.62 | $0.66 |
| High | $0.53 | $0.55 | $0.59 | $0.62 | $0.62 | $0.66 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |